GRHL2 and non-small cell lung carcinoma: Towards this goal, in this study, we established resistance to EGFR inhibition in NSCLC cells and identified novel parallel mechanisms by which the transcription factor, grainyhead-like 2 (GRHL2), and E-cadherin drive drug resistance.